Omnicell’s leadership shift and index inclusion refocus attention on healthcare automation, cloud platforms, execution, and ...

Well, good afternoon, everyone. I'd like to welcome everyone here to a presentation from Omnicell. Very pleased to have the management team here today. Thank you for making the trip. You probably ...

Omnicell is rated Buy, with Q1 results showing structural margin improvement and a 660 bps operating margin jump. Q1 revenue grew 15% Y/Y to $310M, with non-GAAP EPS of $0.55 beating guidance by 53% ...